scholarly journals OP007/#276 Phase I study of mirvetuximab soravtansine (MIRV) and rucaparib for recurrent endometrial, ovarian, fallopian tube or primary peritoneal cancer

2021 ◽  
Author(s):  
F Backes ◽  
J Fowler ◽  
L Copeland ◽  
L Wei ◽  
D O’Malley ◽  
...  
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer

scholarly journals Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

2006 ◽  
Vol 12 (18) ◽  
pp. 5503-5510 ◽  
Author(s):  
Paul Sabbatini ◽  
Jakob Dupont ◽  
Carol Aghajanian ◽  
Felicia Derosa ◽  
Elizabeth Poynor ◽  
...  
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer

Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

2007 ◽  
Vol 13 (13) ◽  
pp. 4026.1-4026
Author(s):  
Birgit C. Schultes ◽  
L. Mary Smith ◽  
Christopher F. Nicodemus
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer
Sign in / Sign up

Export Citation Format

Share Document